Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (411-420 of 548) with videos related to

Pageof 55
Sort By:
Parkinsonism & Related Disorders|May 19, 2009
Adenosine, adenosine A 2A antagonists, and Parkinson's diseaseP Jenner, A Mori, R Hauser, et al.
Journal of Neural Transmission|January 1, 1987
Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapineN M Rupniak, S A Prestwich, R W Horton, et al.
Advances in Neurology|January 1, 1975
Relationship between animal models and clinical parkinsonismC D Marsden, R C Duvoisin, P Jenner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977
Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.
Neuroscience|September 5, 2002
Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosetsB Dass, M M Iravani, M J Jackson, et al.
European Journal of Pharmacology|November 19, 1981
Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.
Neuropharmacology|November 1, 1989
Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.
Psychopharmacology|April 2, 1999
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 17, 2002
Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeysL Lyras, B-Y Zeng, G McKenzie, et al.
Clinical Neuropharmacology|July 15, 2000
Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmosetL A Smith, M G Jackson, C Bonhomme, et al.
Pageof 55

Showing results (411-420 of 548) with videos related to

Sort By:
Pageof 55
Parkinsonism & Related Disorders|May 19, 2009
Adenosine, adenosine A 2A antagonists, and Parkinson's diseaseP Jenner, A Mori, R Hauser, et al.
Journal of Neural Transmission|January 1, 1987
Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapineN M Rupniak, S A Prestwich, R W Horton, et al.
Advances in Neurology|January 1, 1975
Relationship between animal models and clinical parkinsonismC D Marsden, R C Duvoisin, P Jenner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977
Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.
Neuroscience|September 5, 2002
Behavioural and immunohistochemical changes following supranigral administration of sonic hedgehog in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosetsB Dass, M M Iravani, M J Jackson, et al.
European Journal of Pharmacology|November 19, 1981
Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.
Neuropharmacology|November 1, 1989
Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.
Psychopharmacology|April 2, 1999
Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 17, 2002
Chronic high dose L-DOPA alone or in combination with the COMT inhibitor entacapone does not increase oxidative damage or impair the function of the nigro-striatal pathway in normal cynomologus monkeysL Lyras, B-Y Zeng, G McKenzie, et al.
Clinical Neuropharmacology|July 15, 2000
Transdermal administration of piribedil reverses MPTP-induced motor deficits in the common marmosetL A Smith, M G Jackson, C Bonhomme, et al.
Pageof 55